248 related articles for article (PubMed ID: 17332908)
1. In vitro synergy of baicalein and gentamicin against vancomycin-resistant Enterococcus.
Chang PC; Li HY; Tang HJ; Liu JW; Wang JJ; Chuang YC
J Microbiol Immunol Infect; 2007 Feb; 40(1):56-61. PubMed ID: 17332908
[TBL] [Abstract][Full Text] [Related]
2. Synergy study of vancomycin or teicoplanin plus gentamicin against enterococci, Staphylococcus aureus and coagulase-negative staphylococci by time-kill method.
Thamlikitkul V
J Med Assoc Thai; 1991 Dec; 74(12):669-74. PubMed ID: 1839906
[TBL] [Abstract][Full Text] [Related]
3. Time-kill and synergism studies of ceftobiprole against Enterococcus faecalis, including beta-lactamase-producing and vancomycin-resistant isolates.
Arias CA; Singh KV; Panesso D; Murray BE
Antimicrob Agents Chemother; 2007 Jun; 51(6):2043-7. PubMed ID: 17438057
[TBL] [Abstract][Full Text] [Related]
4. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
[TBL] [Abstract][Full Text] [Related]
5. Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.
Sandoe JA; Wysome J; West AP; Heritage J; Wilcox MH
J Antimicrob Chemother; 2006 Apr; 57(4):767-70. PubMed ID: 16464896
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of vancomycin activity by phenothiazines against vancomycin-resistant Enterococcus faecium in vitro.
Rahbar M; Mehrgan H; Hadji-nejad S
Basic Clin Pharmacol Toxicol; 2010 Aug; 107(2):676-9. PubMed ID: 20353486
[TBL] [Abstract][Full Text] [Related]
7. Time-kill study and synergistic activity of cell-wall inhibitor antibiotics in combination with gentamicin against Enterococcus faecalis and Enterococcus faecium.
Aligholi M; Emaneini M; Taherikalani M; Shahsavan S; Jabalameli F; Asadollahi P; Khoramian B; Eslampour MA
Acta Microbiol Immunol Hung; 2011 Sep; 58(3):219-26. PubMed ID: 21983323
[TBL] [Abstract][Full Text] [Related]
8. Serum bactericidal activities of high-dose daptomycin with and without coadministration of gentamicin against isolates of Staphylococcus aureus and Enterococcus species.
DeRyke CA; Sutherland C; Zhang B; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2006 Nov; 50(11):3529-34. PubMed ID: 17065618
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin synergy with rifampicin and ampicillin against vancomycin-resistant enterococci.
Rand KH; Houck H
J Antimicrob Chemother; 2004 Mar; 53(3):530-2. PubMed ID: 14963062
[TBL] [Abstract][Full Text] [Related]
10. Antibacterial activity of phytochemicals isolated from Erythrina zeyheri against vancomycin-resistant enterococci and their combinations with vancomycin.
Sato M; Tanaka H; Oh-Uchi T; Fukai T; Etoh H; Yamaguchi R
Phytother Res; 2004 Nov; 18(11):906-10. PubMed ID: 15597305
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
13. In vitro activity of cefepime, imipenem, tigecycline, and gentamicin, alone and in combination, against extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
Cha R
Pharmacotherapy; 2008 Mar; 28(3):295-300. PubMed ID: 18294108
[TBL] [Abstract][Full Text] [Related]
14. Combination effects of baicalein with antibiotics against oral pathogens.
Jang EJ; Cha SM; Choi SM; Cha JD
Arch Oral Biol; 2014 Nov; 59(11):1233-41. PubMed ID: 25129811
[TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics.
Sakagami Y; Kajimura K; Wijesinghe WM; Dharmaratne HR
Planta Med; 2002 Jun; 68(6):541-3. PubMed ID: 12094300
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effects of baicalein with ciprofloxacin against NorA over-expressed methicillin-resistant Staphylococcus aureus (MRSA) and inhibition of MRSA pyruvate kinase.
Chan BC; Ip M; Lau CB; Lui SL; Jolivalt C; Ganem-Elbaz C; Litaudon M; Reiner NE; Gong H; See RH; Fung KP; Leung PC
J Ethnopharmacol; 2011 Sep; 137(1):767-73. PubMed ID: 21782012
[TBL] [Abstract][Full Text] [Related]
18. In vitro synergistic antimicrobial effect of imipenem and colistin against an isolate of multidrug-resistant Enterobacter cloacae.
Lin KH; Chuang YC; Lee SH; Yu WL
J Microbiol Immunol Infect; 2010 Aug; 43(4):317-22. PubMed ID: 20688292
[TBL] [Abstract][Full Text] [Related]
19. Synergistic activity of vancomycin and teicoplanin alone and in combination with streptomycin against Enterococcus faecalis strains with various vancomycin susceptibilities.
Babalola CP; Patel KB; Nightingale CH; Nicolau DP
Int J Antimicrob Agents; 2004 Apr; 23(4):343-8. PubMed ID: 15081082
[TBL] [Abstract][Full Text] [Related]
20. Comparison of vancomycin-resistant enterococci isolates from human, poultry and pigs in Korea.
Seo KS; Lim JY; Yoo HS; Bae WK; Park YH
Vet Microbiol; 2005 Apr; 106(3-4):225-33. PubMed ID: 15778028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
